Seven West Media shows a strong focus on ASX-listed medtech company Orthocell, a relatively unknown firm outside specialist circles. Orthocell, based in Perth, produces cell regeneration therapies and was spun out of the University of Western Australia in 2007.
The company maintains a market capitalization around $300 million, having surged approximately 80% over the past year. Despite its growth, Orthocell remains one of many small medtech companies listed on the ASX.
"Most people wouldn’t have heard of Orthocell. It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies."
Tracking companies, people, and topics relevant to your interests is essential in today’s media landscape.
Author’s summary: Seven West Media’s notable attention to the emerging Perth medtech firm Orthocell highlights its potential, amid a broader landscape of small but promising ASX-listed companies.